SMTL ID : 3c09.1 (1 other biounit)

Crystal structure the Fab fragment of matuzumab (Fab72000) in complex with domain III of the extracellular region of EGFR

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.20 Å

Oligo State

hetero-1-1-1-mer

Ligands

4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG.1: 10 residues within 4Å: Chain C: S.18, L.19, S.20, N.22, T.24, N.25, V.44, T.52, T.54 Ligands: NAG.2 6 PLIP interactions: 6 interactions with chain C Hydrophobic interactions: C:V.44 Hydrogen bonds: C:L.19, C:S.20, C:N.22, C:N.25, C:T.52 NAG.2: 3 residues within 4Å: Chain C: D.17 Ligands: NAG.1, BMA.3 No protein-ligand interaction detected (PLIP) NAG.4: 2 residues within 4Å: Chain C: K.30, N.31 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:K.30, C:N.31 NAG.5: 1 residues within 4Å: Chain C: N.83 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:N.83

1 x BMA: beta-D-mannopyranose(Non-covalent)

BMA.3: 2 residues within 4Å: Chain C: D.17 Ligands: NAG.2 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:D.17

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schmiedel, J. et al., Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization. Cancer Cell (2008)

Release Date

2008-04-15

Peptides

Matuzumab Fab Light chain: A
Matuzumab Fab Heavy chain: B
Epidermal growth factor receptor: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

C
D

Matuzumab Fab Light chain

Matuzumab Fab Heavy chain

Epidermal growth factor receptor

Related Entries With Identical Sequence